Company

Abbvie Inc ABBV

Tracked across 15 disclosed holders on Protégé.

11 tracked investors, latest 13F quarter ending 30 Jun 2026 · 4 members of Congress · latest filing 18 Sep 2026

Held by these investors

All of 11 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Voleon Group0.8%$43.5M2026-06-302026-08-14
Woodline Partners0.7%$228.3M2026-06-302026-08-14
Marshall Wace0.6%$752.5M2026-06-302026-08-13
Jain Global0.6%$49.8M2026-06-302026-08-14
Adage Capital Management0.6%$402.3M2026-06-302026-08-14
Hudson Bay Capital Management0.5%$101.3M2026-06-302026-08-14
Ken Griffin0.5%$797.6M2026-06-302026-08-14
Brevan Howard Asset Management0.4%$29.0M2026-06-302026-08-14
Voloridge Investment Management0.4%$95.7M2026-06-302026-08-14
D. E. Shaw & Co.0.3%$529.0M2026-06-302026-08-14
Israel Englander0.3%$381.6M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Pete Sessions0 buys / 1 sell-$33K2026-09-14
Josh Gottheimer0 buys / 1 sell-$8K2026-05-05
Marjorie Greene1 buy / 0 sells$8K2024-11-20
Julie Johnson0 buys / 1 sell-$8K2025-12-18

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for ABBV